Skip to main content

“a cur” for Zoey 2023

A campaign by: Dennis & Bonnie Adair / $20,000 Goal
32 Donors
Raised Percent :

93.63% Funded
, United States (US)
Share this campaign:

You may recall that in 2022, when Zoey was asked what her dream was, she spelled out “a cur” using her eye gaze device to select each letter.  Zoey had a rough start to 2023 due to having to go through bilateral hip surgery in January.  Ever the trooper, she rebounded more quickly than expected and despite additional therapy, found energy to join a Girl Scouts Brownie Troop, and recently has participated in Challenger Cheering.  She continues with therapeutic horseback riding, and won the “Guts and Grit” award for her determination to get back to riding after surgery.  She is doing great in school, now spelling more difficult words using eye gaze, such as the word “chocolate” when asked what she would want on a donut.

Please help us achieve “a cur” for Rett syndrome with a generous donation to our 2023 campaign.  We exceeded our $8,000 goal last year.  This year, I am asking you to collectively match our $10,000 donation.  If you haven’t donated before, or for some time, please donate this year.  The attached word document has a link to the crowdfunding website as well as other information if you prefer to call or send a check.  If you have any issues or need help donating, please contact us and we will help.

Rett Syndrome Research Trust (RSRT) accomplishes a lot with limited resources and achieving a cure is their only mission.  They hope to eliminate the need for RSRT to exist.  Taysha, a biotech company, started their gene replacement clinical trial in 2023 in Canada on two adults so far, assisted by RSRT-supported research.  Thus far the first patient is showing improvement and the clinical trial is being expanded to more participants. Another company, Neurogene, has achieved FDA approval to begin a pediatric gene replacement trial in the U.S. in the near future.  RSRT continues to promote multiple strategies, including MECP2 Reactivation, RNA and gene editing, and several of these strategies are on track for becoming clinical trials and ultimately treatments or a cure.  Because of RSRT strategies, there are eight biopharmaceutical companies with genetic based treatments for Rett Syndrome in their drug development pipelines.

There is hope but we need your help to achieve “a cur”.

Dennis and Bonnie

Make a Donation

Donation Amount
Minimum amount is $ Maximum amount is $10000
Name Donation Amount Date
John Stachowiak $250 February 26, 2024
Bayer matching gift $750 February 15, 2024
Thomas Fowlston $100 February 05, 2024
Hershey's match M Adair $200 January 22, 2024
Hershey's match Primost $100 January 22, 2024
Sergio Flores $100 January 02, 2024
Michael Adair $200 January 01, 2024
Patsy Primost $100 December 29, 2023
Hershey's match Hnatishion $50 December 21, 2023
Hershey's match Fisher $100 December 05, 2023
Pamela & Mel Kerns $75 December 04, 2023
John Hnatishion $50 November 28, 2023
Jeff Kemmerer $250 November 19, 2023
Gretchen Fisher $100 November 17, 2023
David Tacka $1,500 November 14, 2023
Deborah & Bill Buckfelder $250 November 06, 2023
Matthew Freidly $100 November 06, 2023
Matthew & Aubrey Lebo $500 November 04, 2023
James Steeley $250 November 04, 2023
Scott Buesking $100 November 01, 2023
Wesley Petery $750 October 24, 2023
Nancy & Richard Gates $1,000 October 23, 2023
Jane Deck $100 October 21, 2023
Jeffrey Doane $500 October 20, 2023
Patricia Peffley $200 October 16, 2023
Bethany & Mark Novis $400 October 16, 2023
Pamela Bucher $75 October 14, 2023
Gerald Urich $150 October 12, 2023
Martha Petery $100 October 11, 2023
Charles Mackey $75 October 10, 2023
Virginia Edleman $250 October 10, 2023
Bonnie & Dennis Adair $10,000 October 10, 2023